Scientists test different injection methods for skin condition drug
NCT ID NCT07264335
Summary
This early-stage study aims to understand how different injection devices affect how the body absorbs SHR-1819, a potential treatment for atopic dermatitis (eczema). Researchers will enroll 160 healthy volunteers to compare the drug's absorption and safety when delivered through different injection methods. The study focuses on measuring drug levels in the blood and monitoring for any side effects, rather than testing how well the drug treats eczema symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of University of Science and Technology of China
Hefei, Anhui, 230000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.